Skip to search formSkip to main contentSkip to account menu

Human poliovirus 2

Known as: Lansing Virus, Poliovirus Type 2 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Human poliovirus

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Progress Toward Containment of Poliovirus Type 2 — Worldwide, 2017
The Global Polio Eradication Initiative (GPEI) continues to make progress toward the eradication target. Only one of the three… 
2015
2015
Mapping of the epitopes of poliovirus type 2 in complex with antibodies.
2002
2002
In vitro antiviral activity of thirty-six plants from La Réunion Island.
1997
1997
Randomized comparison of early and late vaccination with inactivated poliovirus vaccine after allogeneic BMT
Forty-five adult HLA-matched sibling BMT recipients were randomized to receive inactivated poliovirus vaccine (IPV) at 6, 8 and… 
1991
1991
Analysis of neutralization-escape mutants selected from a mouse virulent type 1/type 2 chimeric poliovirus: identification of a type 1 poliovirus with antigenic site 1 deleted.
A chimeric type 1/type 2 poliovirus (v510), in which the antigenic site 1 (Ag1) of poliovirus type 1 (PV-1) Mahoney was replaced… 
1990
1990
A new antigenic site of poliovirus recognized by an intertypic cross-neutralizing monoclonal antibody.
1989
1989
Anti-thymocyte serum delays clearance of poliovirus from the mouse central nervous system
Highly Cited
1988
Highly Cited
1988
Engineering a poliovirus type 2 antigenic site on a type 1 capsid results in a chimaeric virus which is neurovirulent for mice.
Poliovirus type 2 (PV‐2) Lansing strain produces a fatal paralytic disease in mice after intracerebral injection, whereas… 
1980
1980
Sequence of picornavirus RNAs containing a radioiodinated 5'-linked peptide reveals a conserved 5' sequence.
Virion RNA (vRNA) from poliovirus type 1 (PV1), poliovirus type 2 (PV2), and coxsackie virus B1 (Cox B1) were treated with… 
Highly Cited
1975
Highly Cited
1975
The effects of concanavalin A on the early events of infection by rhinovirus type 2 and poliovirus type 2.
The effect of concanavalin A (Con A) on the course of early infection of HeLa cells with purified radioactive human rhinovirus… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)